Report of the Audit Committee on the Supervision of the Accounting Firm's Responsibilities
Shandong Wohua Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "the Company") appointed Zhongxi Accounting Firm (Special General Partnership) (hereinafter referred to as "Zhongxi") as the auditing institution for the Company's 2025 financial report and internal control audit. In accordance with the provisions and requirements of the Company Law, Securities Law, Guidelines for the Governance of Listed Companies, Management Measures for the Appointment of Accounting Firms by State-owned Enterprises and Listed Companies, and the Shenzhen Stock Exchange's Self-Regulatory Guidelines No. 1 for Main Board Listed Companies, the Audit Committee of the Board of Directors has diligently fulfilled its responsibilities. The following is the report on the supervision of the accounting firm by the Audit Committee for the 2025 fiscal year:
1. Basic Information of the 2025 Annual Audit Accounting Firm
- Basic Information
- Firm Name: Zhongxi Accounting Firm (Special General Partnership)
- Establishment Date: November 28, 2013
- Organizational Form: Special General Partnership
- Registered Address: Room 1101, 11th Floor, No. 11, Chongwenmen Outer Street, Dongcheng District, Beijing
- Chief Partner: Zhang Zenggang
As of the end of 2024, Zhongxi had 102 partners, 442 certified public accountants, and a total of 1,456 employees, with 2,330 certified public accountants having signed audit reports for securities services. In 2024, the firm served over 8,800 clients, achieving total revenue of 418.4583 million yuan (audited), including audit service revenue of 365.7589 million yuan (audited) and securities service revenue of 122.6014 million yuan (audited). The firm served 40 listed company clients in 2024.